Isotretinoin capsule exports are shaped as much by Pregnancy Prevention Programme packaging and dispensing rules as by dose strength.
Isotretinoin is one of the few oral molecules where carton artwork and the dispensing cycle are regulated almost as tightly as the capsule itself. Most markets that permit isotretinoin attach a Pregnancy Prevention Programme: a pregnancy warning pictogram on the pack, a patient reminder or acknowledgement card, and prescribing cycles tied to a recent pregnancy test for patients who can become pregnant. M Care supplies isotretinoin capsules from 5mg to 30mg, sourced from WHO-GMP certified Indian manufacturers, with pack documentation built to the importing market's own PPP specification.
Isotretinoin exporter and bulk supplier from India.
Bulk isotretinoin shipments travel with the standard export set: a certificate of pharmaceutical product or free sale certificate, a certificate of analysis per batch, and the manufacturer's WHO-GMP certificate, alongside M Care's own CDSCO export licence and ISO 9001:2015 certificate. Because isotretinoin is teratogenic, pack artwork is the variable that changes most between destinations: the outer carton and patient information leaflet must carry the importing market's specific pregnancy warning pictogram and any required patient card, so artwork proofs are confirmed against the buyer's national PPP requirement before a production run is released. Isotretinoin capsules are light and moisture sensitive and are packed accordingly for the transit route and climate zone.
Source
WHO-GMP-certified Indian manufacturing line, named on every quote.
Minimum order
No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.
Pricing
On request. Indicative FOB or CIF quote, formal proforma on confirmation.
Incoterms
EXW, FOB, CIF, CIP or DAP.
Payment
Letter of credit (sight or usance) and telegraphic transfer.
Documentation
WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.
Shelf-life
Minimum remaining shelf-life agreed per order and confirmed on the proforma.
Response
Availability and CoPP status within two working days; pre-alert documents before dispatch.
Systemic retinoid (vitamin A derivative), sourced and documented for export.
Isotretinoin's export profile is defined by the Pregnancy Prevention Programme (PPP) that most regulated markets attach to it, not by potency alone. Because the molecule carries an established teratogenic risk, agencies including the FDA, EMA and MHRA require a pregnancy warning pictogram on the outer carton, a patient reminder or acknowledgement card inside the pack, and prescribing or dispensing cycles tied to a recent pregnancy test for patients who can become pregnant. Clinically, isotretinoin is a systemic retinoid used for severe, treatment-resistant nodular acne after conventional oral and topical therapy has failed; it works by reducing sebaceous gland size and sebum output. M Care's catalogue holds only the oral capsule form, across 5mg, 10mg, 20mg and 30mg strengths, with zero fixed-dose combination lines.
Active ingredient
Isotretinoin. Systemic retinoid (vitamin A derivative).
Forms and strengths
5 mg; 10 mg; 20 mg; 30 mg.
Indications
Isotretinoin is a systemic retinoid indicated for severe, treatment-resistant nodular acne, supplied by M Care as an oral capsule sourced from WHO-GMP certified Indian manufacturers, with pack labeling and documentation built to each importing market's Pregnancy Prevention Programme requirement.
Administration
Oral. Capsule.
Documentation
Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.
Hospital pharmacies, licensed importers and tender desks across our export markets.
India is our origin. We do not sell into the Indian market.
Isotretinoin buyers are concentrated among licensed importers and hospital or dermatology-clinic procurement desks in markets that already run their own Pregnancy Prevention Programme: the UK, the EU, Gulf Cooperation Council states, and parts of Southeast Asia and Latin America with retinoid-specific dispensing rules. Regulatory affairs teams typically approach M Care to source capsules for a market authorisation dossier or a tender that already specifies pack-level PPP labeling. African importers most often approach M Care during initial national registration of isotretinoin, since a first-time market authorisation typically has to precede any import. India is the country of manufacture and origin only; it is never a served destination for this molecule.
GCC registration routes
Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.
UK unlicensed routes
Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.
Tender desks
Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.
Dossier support
CTD documentation from the sourcing manufacturer, compiled for your regulator's format.
What the dispensing pharmacist checks on isotretinoin.
A reviewing pharmacist checks isotretinoin against Pregnancy Prevention Programme criteria first: pregnancy status confirmed by a recent negative test, effective contraception in place for patients who can become pregnant, and a prescribing or dispensing cycle that follows the local PPP window. Isotretinoin is teratogenic at low exposure, so batch traceability is checked against the certificate of analysis as a compliance matter, not only a quality one. Bioavailability is formulation dependent and improves with food, so pharmacists compare whether a formulation is a standard or a micronised, lower food-effect capsule when reviewing an equivalence dossier. Neuropsychiatric changes, mood and rare reports of intracranial hypertension are monitored during therapy, and concurrent tetracycline use is generally avoided for the same intracranial pressure reason. Hepatic transaminases and serum lipids, particularly triglycerides, are checked at baseline and periodically, since isotretinoin can raise both. M Care does not provide dosing guidance; that responsibility sits with the prescriber.
The documentation pack a regulator actually asks for.
Every isotretinoin batch ships with a certificate of analysis confirming assay, dissolution, related substances and content uniformity against pharmacopoeial limits, together with the manufacturer's WHO-GMP certificate and a certificate of pharmaceutical product or free sale certificate for the importing authority. M Care adds its CDSCO export licence and ISO 9001:2015 quality management certificate; M Care is a merchant-exporter and does not hold and cannot claim WHO-GMP or WHO-PQ status in its own name, since those certifications apply to the manufacturing site, not the trading company. Because isotretinoin carries a mandatory Pregnancy Prevention Programme in most regulated markets, the documentation pack also includes carton and patient information leaflet artwork proofs showing the pregnancy warning pictogram and any patient acknowledgement card the destination market requires, checked against that market's own PPP wording before dispatch. Stability data and shelf-life statements are provided against the manufacturer's registered stability study, and batch-specific documentation is available on request to support a regulatory affairs team's own market authorisation or tender submission.
CoA and MoA, per batch
Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.
CoPP, WHO-GMP, MFG licence
Certificate of pharmaceutical product and site GMP certification issued via CDSCO channels, naming the actual manufacturing site.
CTD Module 3
Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.
Pack insert, labels, artwork
Destination-language patient information and labelling to the local regulator's standard, locked before shipment.
Pharmacovigilance
A named PV contact arranged in the destination market where the registration requires one.
What a buyer should know before this line enters a formulary.
We publish the awkward facts alongside the useful ones. A supplier who omits them is not saving you work, only deferring it.
Contraindicated in pregnancy; established teratogen with embryo-fetal risk at any dose
Prescribing and dispensing controlled under Pregnancy Prevention Programme (PPP) / REMS frameworks in most markets that permit isotretinoin, including FDA iPLEDGE (US) and EU/UK PPP requirements
Prescription-only medicine; not narcotic-scheduled but subject to PPP-driven dispensing restrictions in most markets
M Care is a merchant-exporter and does not hold WHO-GMP or WHO-PQ certification in its own name; certifications belong to the manufacturing site
India is not a served market for this molecule; India is the country of origin and manufacture only
M Care's catalogue covers only the oral capsule dosage form; tablet, injectable, oral suspension, topical, ophthalmic, inhaled and sachet forms of isotretinoin are not stocked
Adjacent lines procurement desks order alongside isotretinoin.
Molecule · strength · volume · destination. One working day to a quote.
- Send us the specifics. Form and strength, pack preference, destination market and indicative volume for isotretinoin.
- We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
- Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
- Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
- After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Isotretinoin supply, the specific questions.
Does M Care hold WHO-GMP or WHO-PQ certification directly?
No. M Care is a merchant-exporter, not a manufacturer, and holds ISO 9001:2015 and a CDSCO export licence in its own name. Every isotretinoin batch is sourced from WHO-GMP certified Indian manufacturing sites, and the manufacturer's own certificate travels with the batch documentation.
What does the Pregnancy Prevention Programme mean for an isotretinoin shipment?
Most regulated markets require the outer carton and patient leaflet to carry a pregnancy warning pictogram and, in many cases, a patient acknowledgement card, alongside a prescribing or dispensing cycle tied to a recent pregnancy test. M Care confirms artwork against the destination market's specific PPP requirement before a production run is released.
Which isotretinoin strengths and dosage form does M Care supply?
M Care supplies isotretinoin as an oral capsule only, in 5mg, 10mg, 20mg and 30mg strengths across 26 catalogue lines. M Care does not supply isotretinoin as a tablet, injection, oral suspension, topical, ophthalmic, inhaled or sachet formulation; those forms exist clinically but sit outside the current catalogue.
Does M Care ship isotretinoin to India?
No. India is the country of manufacture and origin only. M Care's served markets sit outside India: the UK, the EU, Gulf Cooperation Council states, Africa, Latin America, Southeast Asia and CIS markets that permit isotretinoin under their own registration and PPP requirements.
What documentation accompanies a bulk isotretinoin order?
Each order ships with a certificate of analysis per batch, the manufacturer's WHO-GMP certificate, a certificate of pharmaceutical product or free sale certificate, M Care's CDSCO export licence and ISO 9001:2015 certificate, plus carton and leaflet artwork proofs matching the destination market's PPP labeling requirement.
Why does isotretinoin need particular handling in transit?
Isotretinoin capsules are light and moisture sensitive, and because the molecule is teratogenic, batch traceability and pack integrity are treated as compliance issues as much as quality ones. M Care packs and documents shipments to the transit route and climate zone and can confirm chain-of-custody detail a regulatory affairs team needs for its own dossier.
Is isotretinoin a controlled substance for export purposes?
Isotretinoin is not narcotic-scheduled; it is prescription-only and subject to Pregnancy Prevention Programme dispensing rules in most markets that permit it, rather than controlled-substance scheduling. Buyers should confirm their own market's registration and PPP status before ordering, since requirements vary by country.
Who stands behind this page, and where its statements come from.
Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-08-22.
This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.
Send the specifics. You'll have a price inside one working day.
Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.